Contact
Please use this form to send email to PR contact of this press release:
XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
TO:
Please use this form to send email to PR contact of this press release:
XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
TO: